| Product Code: ETC9517148 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Neurology Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Neurology Market - Industry Life Cycle |
3.4 Suriname Neurology Market - Porter's Five Forces |
3.5 Suriname Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Suriname Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Suriname Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Suriname |
4.2.2 Growing awareness about neurology and mental health issues in the country |
4.2.3 Advancements in medical technology and treatment options for neurological conditions |
4.3 Market Restraints |
4.3.1 Limited access to specialized neurology care in remote areas of Suriname |
4.3.2 High cost of neurology treatments and medications for patients |
4.3.3 Shortage of skilled neurology professionals in the country |
5 Suriname Neurology Market Trends |
6 Suriname Neurology Market, By Types |
6.1 Suriname Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Neurology Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Neurology Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.4 Suriname Neurology Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.5 Suriname Neurology Market Revenues & Volume, By Neuro-infectious Diseases, 2021- 2031F |
6.1.6 Suriname Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Neurology Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Suriname Neurology Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.3 Suriname Neurology Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.4 Suriname Neurology Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.5 Suriname Neurology Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.6 Suriname Neurology Market Revenues & Volume, By Stroke, 2021- 2031F |
6.2.7 Suriname Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Neurology Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Neurology Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Suriname Neurology Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Suriname Neurology Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Suriname Neurology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Neurology Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Suriname Neurology Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 Suriname Neurology Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 Suriname Neurology Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Neurology Market Import-Export Trade Statistics |
7.1 Suriname Neurology Market Export to Major Countries |
7.2 Suriname Neurology Market Imports from Major Countries |
8 Suriname Neurology Market Key Performance Indicators |
8.1 Average wait time for neurology appointments |
8.2 Number of neurology clinics or facilities in Suriname |
8.3 Patient satisfaction with neurology services |
8.4 Percentage of population receiving regular neurological screenings |
8.5 Number of research studies or clinical trials related to neurology taking place in Suriname |
9 Suriname Neurology Market - Opportunity Assessment |
9.1 Suriname Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Neurology Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Suriname Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Suriname Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Neurology Market - Competitive Landscape |
10.1 Suriname Neurology Market Revenue Share, By Companies, 2024 |
10.2 Suriname Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here